Amgen INC (AMGN) Stake Boosted by United Capital Financial Advisers Llc

February 22, 2018 - By Marguerite Chambers

Investors sentiment decreased to 0.99 in Q3 2017. Its down 0.16, from 1.15 in 2017Q2. It dived, as 58 investors sold AMGN shares while 511 reduced holdings. 108 funds opened positions while 453 raised stakes. 555.05 million shares or 0.41% less from 557.32 million shares in 2017Q2 were reported. Cap Ok holds 0.02% or 1,416 shares in its portfolio. Greylin Investment Mangement Inc holds 14,057 shares or 0.6% of its portfolio. Gotham Asset Llc invested 0.65% in Amgen Inc. (NASDAQ:AMGN). Legacy Private owns 7,682 shares. Balyasny Asset Limited Liability Corporation has invested 0.04% in Amgen Inc. (NASDAQ:AMGN). Paradigm Asset Mngmt Company Ltd invested in 2,600 shares or 0.13% of the stock. Alpha Windward Limited Liability Corp has invested 0.2% in Amgen Inc. (NASDAQ:AMGN). Bokf Na accumulated 86,694 shares or 0.48% of the stock. American Research And Management holds 4,852 shares or 0.29% of its portfolio. Renaissance Inv Llc invested in 1,611 shares or 0.13% of the stock. Crestwood Advsr Group Inc Limited Liability holds 3,227 shares or 0.05% of its portfolio. Usca Ria Ltd Liability Co, Texas-based fund reported 36,423 shares. Essex Fincl Services holds 52,496 shares or 2.4% of its portfolio. Arete Wealth Limited Liability Corporation invested in 0.56% or 7,507 shares. First Bancshares holds 0.84% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 6,732 shares.

Since October 9, 2017, it had 0 insider buys, and 4 insider sales for $1.10 million activity.

United Capital Financial Advisers Llc increased its stake in Amgen Inc (AMGN) by 370.22% based on its latest 2017Q3 regulatory filing with the SEC. United Capital Financial Advisers Llc bought 124,552 shares as the company’s stock declined 9.68% while stock markets rallied. The institutional investor held 158,195 shares of the biological products (no diagnostic substances) company at the end of 2017Q3, valued at $29.50M, up from 33,643 at the end of the previous reported quarter. United Capital Financial Advisers Llc who had been investing in Amgen Inc for a number of months, seems to be bullish on the $131.45 billion market cap company. The stock decreased 0.30% or $0.55 during the last trading session, reaching $182.43. About 4.05M shares traded or 17.77% up from the average. Amgen Inc. (NASDAQ:AMGN) has risen 5.27% since February 22, 2017 and is uptrending. It has underperformed by 11.43% the S&P500.

United Capital Financial Advisers Llc, which manages about $9.56 billion and $11.79B US Long portfolio, decreased its stake in Ishares Us Basic Materials (IYM) by 35,566 shares to 243,216 shares, valued at $23.30 million in 2017Q3, according to the filing. It also reduced its holding in First Trust Dow Jones Internet Etf (FDN) by 47,793 shares in the quarter, leaving it with 243,951 shares, and cut its stake in Powershares Dwa Energy Momentum Etf (PXI).

More important recent Amgen Inc. (NASDAQ:AMGN) news were published by: Fool.com which released: “The case for Amgen” on February 21, 2018, also Reuters.com published article titled: “Amgen profit misses Street view; sees broad tax reform benefits”, Seekingalpha.com published: “Amgen As A Source Of Funds” on February 12, 2018. More interesting news about Amgen Inc. (NASDAQ:AMGN) was released by: Finance.Yahoo.com and their article: “3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Edwards Lifesciences Corp (EW …” with publication date: February 02, 2018.

Amgen Inc. (NASDAQ:AMGN) Ratings Coverage

Among 25 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Amgen Inc. had 86 analyst reports since August 3, 2015 according to SRatingsIntel. UBS maintained the stock with “Neutral” rating in Wednesday, July 26 report. The stock has “Neutral” rating by Credit Suisse on Tuesday, December 20. The firm has “Hold” rating by BMO Capital Markets given on Friday, October 20. The rating was maintained by Oppenheimer on Wednesday, August 23 with “Buy”. Argus Research downgraded Amgen Inc. (NASDAQ:AMGN) on Wednesday, November 1 to “Hold” rating. The rating was upgraded by Bank of America to “Buy” on Wednesday, February 1. The firm earned “Buy” rating on Monday, February 12 by Mizuho. Mizuho maintained the shares of AMGN in report on Friday, July 14 with “Buy” rating. The company was upgraded on Tuesday, January 23 by Argus Research. The company was upgraded on Thursday, November 5 by Piper Jaffray.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.